Laura and Isaac Perlmutter Cancer Center — New York, New York

Laura and Isaac Perlmutter Cancer Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Laura and Isaac Perlmutter Cancer Center has participated in 19 clinical trials with 11 currently active.

Therapeutic areas: Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms.

Sponsors: Eli Lilly and Company, NYU Langone Health, Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Laura and Isaac Perlmutter Cancer Center?

Laura and Isaac Perlmutter Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Laura and Isaac Perlmutter Cancer Center conducted?

Laura and Isaac Perlmutter Cancer Center has 19 clinical trials on record, with 11 currently active. Their work covers Ovarian Neoplasms, Fallopian Tube Neoplasms, Peritoneal Neoplasms.

Is Laura and Isaac Perlmutter Cancer Center accredited by Crixeo Health?

Yes — Laura and Isaac Perlmutter Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Laura and Isaac Perlmutter Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.